EWA
LABU icon

EverSource Wealth Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

EverSource Wealth Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96K Sell
10
-75
-88% -$14.4K ﹤0.01% 3541
2026
Q1 		$14.1K Buy
85
+75
+750% +$12.3K ﹤0.01% 2728
2025
Q4 		$1.62K Hold
10
– – ﹤0.01% 3570
2025
Q3 		$944 Hold
10
– – ﹤0.01% 3779
2025
Q2 		$571 Sell
10
-88
-90% -$4.67K ﹤0.01% 3870
2025
Q1 		$5.98K Hold
98
– – ﹤0.01% 2412
2024
Q4 		$8.82K Buy
+98
New +$11.5K ﹤0.01% 2069

Other funds holding LABU

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.5B AUM 22.75% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.75B AUM 33.61% 1-Year Est. Return
VPW
Variant Private Wealth Tysons, Virginia $88.9M AUM 25.07% 1-Year Est. Return
HHGA
Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

EverSource Wealth Advisors's LABU Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Direxion Daily S&P Biotech Bull 3X ETF (LABU) stake by 88% in Q2 2026, selling an estimated $14.4K and leaving 10 shares worth $2.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

EverSource Wealth Advisors first reported a position in LABU in Q4 2024 and has held it in 7 quarters since. The position peaked at $14.1K in Q1 2026. 17 funds tracked by Wall St. Rank hold LABU as of Q2 2026.

  • EverSource Wealth Advisors held 10 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $2.96K as of Q2 2026.
  • EverSource Wealth Advisors sold 75 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2026, an estimated $14.4K.
  • Direxion Daily S&P Biotech Bull 3X ETF made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3541 holding.
  • EverSource Wealth Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $14.1K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.